Evaluation of pharmacist clinical interventions in a Dutch hospital setting

Pharmacy World and Science

Volumn 30, Issue 1, 2008, Pages 31-38

  Bosma, Liesbeth ^a,f   Jansman, Frank G A ^a,b   Franken, Anton M ^c   Harting, Johannes W ^a   Van Den Bemt, Patricia M L A ^d,e  

^a Hospital Pharmacy   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c St Lucas Andreas Hospital ^*  (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

^f Apotheek Haagse Ziekenhuizen   (Netherlands)

Author keywords

Clinical pharmacist intervention; Clinical pharmacy; Drug related problem; Hospital pharmacy; Medication Error; Pharmaceutical care; Prescription error; The Netherlands

Indexed keywords

AMIODARONE; AZATHIOPRINE; CARBAMAZEPINE; CISAPRIDE; COUMARIN ANTICOAGULANT; CYCLOSPORIN; DIGOXIN; GENTAMICIN; LITHIUM; METHOTREXATE; PHENYTOIN; THEOPHYLLINE; THYROMIMETIC AGENT; VALPROIC ACID;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROENTEROLOGY; HOSPITAL PHARMACY; HOSPITAL SERVICE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; OBSERVATIONAL METHOD; PHARMACIST; PHYSICIAN; PROSPECTIVE STUDY; RISK ASSESSMENT; WARD; WORK CAPACITY;

AGED; FEMALE; HOSPITAL UNITS; HUMANS; MALE; MEDICATION ERRORS; NETHERLANDS; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; PROSPECTIVE STUDIES;

EID: 36448936041     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9136-9     Document Type: Article

References (21)

1. Van den Bemt PMLA, Egberts TCG, de Jong-van den Berg LTW, Brouwers JRBJ. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321-33.
2. Lustig A. Medication error prevention by pharmacists- An Israeli solution. Pharm World Sci 2000;22(1):21-5.
3. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-7.
4. Scarsi KK, Fotis MA, Noskon GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm 2002;59:2089-92.
5. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW. Pharmacist Participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282(3):267-70.
6. Calvert RT. Clinical pharmacy- a hospital perspective. Br J Clin Pharmacol 1999;47:231-8.
7. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695-700.
8. Needham DS, Wong IC, Campion PD. Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care. Palliat Med. 2002;16(3):219-25.
9. Buurma H, De Smet PA, Leufkens HG, Egberts TCG. Evaluation of the clinical value of pharmacists' modifications of prescription errors. Br J Clin Pharmacol. 2004;58(5):503-11.
10. Buurma H, de Smet PA, van den Hoff OP, Egberts TCG. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001;52(1):85-91.
11. Van den Bemt PMLA, Egberts ACG, Lenderink AW, Verzijl JM, Simons KA, van der Pol WSJCM, Leufkens HGM. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000;22(2):62-6.
12. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a USA consensus panel of experts. Arch Intern Med 2003;163:2716-24.
13. American Society of Health System Pharmacists (ASHP) "Clinical Skills Program", module 3-5, 1993.
14. Overhage M, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities. Am J Health Syst Pharm 1999; 56(23):2444-50.
15. Dutch Scientific Institute for Pharmacy Dutch manual for drug substitution, May 2004. www. WINAp.nl.
16. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997;156:385-91.
17. Van den Bemt PMLA. Costs and benefits of detecting prescribing errors. Thesis: Drug safety in hospitalised patients. Rijksuniversiteit Groningen 2002;Ch 4.2:75-88.
18. Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 1997;54(14):1591-5.
19. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003;23(1):113-32.
20. Van Roon EN, Wu MD, Idzinga F, Van den Bemt PMLA, Jansen TLTA, Houtman PM, Van de Laar, MAFJ, Brouwers JRBJ. A multidisciplinary approach for the assessment of drug interactions with disease-modifying antirheumatic drugs. Thesis Groningen University 2005: Practice research in the field of rheumatoid arthritis.
21. Dale A, Copeland R, Barton R. Precribing errors on medical wards and the impact of clinical pharmacists. Int J Pharm Pract 2003;11:19-24.